Voluntary Directors' Dealings announcement of Dr. Ben J. Lipps

Voluntary Directors' Dealings announcement of Dr. Ben J. Lipps

ID: 292266

(Thomson Reuters ONE) -
MagForce AG /
Voluntary Directors' Dealings announcement of Dr. Ben J. Lipps
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Berlin, Germany, August 29, 2013 - MagForce AG (Frankfurt, Entry Standard,
XETRA: MF6), a leading medical device company in the field of nanomedicine
focused on oncology, announced today that Ben Lipps, designated CEO starting
September 1st, 2013, has disclosed to the Company that he has bought 250,000
shares in MagForce, which represents 1.05% of the Company's outstanding shares.

About MagForce AG

MagForce AG is a leading medical device company in the field of nanomedicine in
oncology, listed in the entry standard (MF6). The Company's proprietary,
NanoTherm(®) therapy, enables the targeted treatment of solid tumors through the
intratumoral generation of heat via activation of superparamagnetic
nanoparticles. NanoTherm(®), NanoPlan(®), and NanoActivator(TM) are components
of the therapy and have received EU-wide regulatory approval as medical devices
for the treatment of brain tumors. MagForce, NanoTherm(®), NanoPlan(®), and
NanoActivator(TM) are trademarks of MagForce AG in selected countries. For more
information, please visit www.magforce.com.


Disclaimer

This release may contain forward-looking statements and information which may be
identified by formulations using terms such as "expects", "aims", "anticipates",
"intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-
looking statements are based on our current expectations and certain
assumptions, which may be subject to a variety of risks and uncertainties. The
results actually achieved by MagForce AG may substantially differ from these




forward-looking statements. MagForce AG assumes no obligation to update these
forward-looking statements or to correct them in case of developments, which
differ from those, anticipated.



Contact:

Anne Hennecke
MC Services AG

T +49 89 210228-18
F +49 89 210228-88
M +49 151 12 555 759


Email: anne.hennecke(at)mc-services.eu


MagForce_Press Release_August 29, 2013:
http://hugin.info/143761/R/1725837/575650.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: MagForce AG via Thomson Reuters ONE
[HUG#1725837]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Pharming redeems final tranche of convertible bond for cash Announcement from Systemair AB (publ) Annual General Meeting 2013
Bereitgestellt von Benutzer: hugin
Datum: 29.08.2013 - 16:37 Uhr
Sprache: Deutsch
News-ID 292266
Anzahl Zeichen: 3156

contact information:
Town:

Berlin



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 187 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Voluntary Directors' Dealings announcement of Dr. Ben J. Lipps"
steht unter der journalistisch-redaktionellen Verantwortung von

MagForce AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von MagForce AG



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z